//Bon Secours joins FDA’s Expanded Access Program to use convalescent plasma as a COVID-19 treatment

Bon Secours joins FDA’s Expanded Access Program to use convalescent plasma as a COVID-19 treatment

Greenville, SC (FOX Carolina) – Wednesday, a spokesperson for Bon Secours announced they have joined the Food and Drug Administration’s national Expanded Access Program for convalescent plasma as a treatment protocol for COVID-19.

Convalescent plasma is plasma from a person who has recovered from the virus and is given to